EOLS
Evolus, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.36
+3.66%Forward multiples
Based on analyst estimates
- P/E forward
- 28.75x
- P/E 2026E
- —
- P/E 2027E
- 21.98x
- P/E 2028E
- 10.92x
- P/S forward
- 1.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -15.73x
- Price / sales
- 1.54x
- Price / cash flow
- -31.61x
Enterprise value
- Enterprise value
- $605.8M
- EV / sales
- 1.91x
- EV / EBITDA
- -84.01x
- EV / EBIT
- -26.12x
- Market cap
- $486.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026